Clinical trial
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
NCT00628498 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
- Lead sponsor
- Jazz Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- September 30, 2016
- Enrollment
- 1,206 (actual)
- Sites
- 125
Conditions
As the registry lists them; a condition with its own page is linked.